522 related articles for article (PubMed ID: 19713956)
1. Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications.
Abel EL; Angel JM; Kiguchi K; DiGiovanni J
Nat Protoc; 2009; 4(9):1350-62. PubMed ID: 19713956
[TBL] [Abstract][Full Text] [Related]
2. Effects of dose and duration of treatment with the tumor-promoting agent, 12-O-tetradecanoylphorbol-13-acetate on mouse skin carcinogenesis.
Verma AK; Boutwell RK
Carcinogenesis; 1980 Mar; 1(3):271-6. PubMed ID: 22283009
[TBL] [Abstract][Full Text] [Related]
3. Toxicology and carcinogenesis studies of pyrogallol (CAS No. 87-66-1) in F344/N rats and B6C3F1/N mice (dermal studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2013 Feb; (574):1-167. PubMed ID: 23518671
[TBL] [Abstract][Full Text] [Related]
4. Isolation of cancer stem cells from skin squamous cell carcinoma.
Joshi P; Ghadi DS; Waghmare SK
Methods Cell Biol; 2022; 171():63-80. PubMed ID: 35953206
[TBL] [Abstract][Full Text] [Related]
5. Tumor progression in Sencar mouse skin as a function of initiator dose and promoter dose, duration, and type.
Ewing MW; Conti CJ; Kruszewski FH; Slaga TJ; DiGiovanni J
Cancer Res; 1988 Dec; 48(24 Pt 1):7048-54. PubMed ID: 3142681
[TBL] [Abstract][Full Text] [Related]
6. A course of very small doses of DMBA, each of them allegedly with no promoting potency, acts with clear synergistic effect as a strong promoter of DMBA-initiated mouse skin carcinogenesis. A comparison of the tumorigenic and carcinogenic effects of DMBA (7,12-dimethylbenz-alpha-anthracene) and TPA (12-O-tetradecanoyl-phorbol-13-acetate) used as initiators and promoters in classical two-stage experimental protocols.
Iversen OH
APMIS Suppl; 1994; 41():1-38. PubMed ID: 7946481
[TBL] [Abstract][Full Text] [Related]
7. A multihit, multistage model of chemical carcinogenesis.
Owens DM; Wei S; Smart RC
Carcinogenesis; 1999 Sep; 20(9):1837-44. PubMed ID: 10469632
[TBL] [Abstract][Full Text] [Related]
8. Susceptibility of 129/SvEv mice in two-stage carcinogenesis protocols to 12-O-tetradecanoylphorbol-13-acetate promotion.
Reiners JJ; Singh KP
Carcinogenesis; 1997 Mar; 18(3):593-7. PubMed ID: 9067561
[TBL] [Abstract][Full Text] [Related]
9. Chemical carcinogens and antigens contribute to cutaneous tumor promotion by depleting epidermal Langerhans cells.
Qu M; Muller HK; Woods GM
Carcinogenesis; 1997 Jun; 18(6):1277-9. PubMed ID: 9214614
[TBL] [Abstract][Full Text] [Related]
10. Triethylenemelamine: an initiator of two-stage carcinogenesis in mouse skin which lacks the potential of a complete carcinogen.
Perrella FW; Boutwell RK
Cancer Lett; 1983 Nov; 21(1):37-41. PubMed ID: 6640512
[TBL] [Abstract][Full Text] [Related]
11. IL-1 alpha, innate immunity, and skin carcinogenesis: the effect of constitutive expression of IL-1 alpha in epidermis on chemical carcinogenesis.
Murphy JE; Morales RE; Scott J; Kupper TS
J Immunol; 2003 Jun; 170(11):5697-703. PubMed ID: 12759452
[TBL] [Abstract][Full Text] [Related]
12. Development of an in vitro model to study carcinogen-induced neoplastic progression of initiated mouse epidermal cells.
Morgan D; Welty D; Glick A; Greenhalgh D; Hennings H; Yuspa SH
Cancer Res; 1992 Jun; 52(11):3145-56. PubMed ID: 1375535
[TBL] [Abstract][Full Text] [Related]
13. Overview of tumor promotion in animals.
Slaga TJ
Environ Health Perspect; 1983 Apr; 50():3-14. PubMed ID: 6347683
[TBL] [Abstract][Full Text] [Related]
14. Role of iron-dextran on 7,12-dimethylbenz(a) anthracene-initiated and croton oil-promoted cutaneous tumorigenesis in normal and pregnant mice.
Rezazadeh H; Nayebi AR; Athar M
Hum Exp Toxicol; 2001 Sep; 20(9):471-6. PubMed ID: 11776409
[TBL] [Abstract][Full Text] [Related]
15. Regression and progression characteristics of papillomas induced by chrysarobin in SENCAR mice.
Battalora MS; Conti CJ; Aldaz CM; Slaga TJ; Johnston DA; DiGiovanni J
Carcinogenesis; 1996 May; 17(5):955-60. PubMed ID: 8640943
[TBL] [Abstract][Full Text] [Related]
16. Oral and dermal exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) induces cutaneous papillomas and squamous cell carcinomas in female hemizygous Tg.AC transgenic mice.
Wyde ME; Braen AP; Hejtmancik M; Johnson JD; Toft JD; Blake JC; Cooper SD; Mahler J; Vallant M; Bucher JR; Walker NJ
Toxicol Sci; 2004 Nov; 82(1):34-45. PubMed ID: 15282402
[TBL] [Abstract][Full Text] [Related]
17. Role of the epidermal growth factor receptor and transforming growth factor alpha in mouse skin carcinogenesis.
DiGiovanni J; Rho O; Xian W; Beltràn L
Prog Clin Biol Res; 1994; 387():113-38. PubMed ID: 7972243
[TBL] [Abstract][Full Text] [Related]
18. Malignant conversion, the first stage in progression, is distinct from phorbol ester promotion in mouse skin.
Hennings H
Basic Life Sci; 1991; 57():31-9; discussion 39-42. PubMed ID: 1814291
[TBL] [Abstract][Full Text] [Related]
19. Analysis of c-Ha-ras gene mutations in skin tumors induced in carcinogenesis-susceptible and carcinogenesis-resistant mice by different two-stage protocols or tumor promoter alone.
Pazzaglia S; Mancuso M; Primerano B; Rebessi S; Biozzi G; Covelli V; Saran A
Mol Carcinog; 2001 Feb; 30(2):111-8. PubMed ID: 11241758
[TBL] [Abstract][Full Text] [Related]
20. Association of carcinoma yield with early papilloma development in SENCAR mice.
Bull RJ; Robinson M; Laurie RD
Environ Health Perspect; 1986 Sep; 68():11-7. PubMed ID: 3780623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
